Cancer Research Aziza Shad Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiong, Y.
Right arrow Articles by Jiang, S.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiong, Y.
Right arrow Articles by Jiang, S.-W.
[Cancer Research 65, 2684-2689, April 1, 2005]
© 2005 American Association for Cancer Research

Molecular Biology, Pathobiology, and Genetics

Histone Deacetylase Inhibitors Decrease DNA Methyltransferase-3B Messenger RNA Stability and Down-regulate De novo DNA Methyltransferase Activity in Human Endometrial Cells

Yuning Xiong1, Sean C. Dowdy1, Karl C. Podratz1, Fan Jin1, John R. Attewell2, Norman L. Eberhardt3,4 and Shi-Wen Jiang1,3

Departments of 1 Obstetrics and Gynecology, 2 Experimental Pathology, 3 Internal Medicine, Division of Endocrinology, and4 Biochemistry and Molecular Biology, Mayo Clinic and Foundation, Rochester, Minnesota

Requests for reprints: Shi-Wen Jiang, Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street, Southwest, Rochester, MN 55905. Phone: 507-255-6588; Fax: 507-255-4828; E-mail: jiang.shiwen{at}mayo.edu.

It is well known that the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) acts synergistically with the DNA methyltransferase (DNMT) inhibitor 5-aza-2'-deoxycytidine (ADC) to reactivate DNA methylation-silenced genes. Moreover, in several studies, TSA was capable of inducing DNA demethylation even in the absence of ADC. Here we describe a mechanism by which HDAC inhibitors affect DNA methylation through their regulation on DNMT3B, a methyltransferase responsible for de novo DNA methylation. Using quantitative real-time PCR and Western blot analysis, we show that TSA down-regulates DNMT3B mRNA and protein expression in human endometrial cancer cells. This decrease in DNMT3B mRNA results in a significant reduction in de novo methylation activities. Further experiments indicated that TSA decreases DNMT3B mRNA stability and reduces its half-life from ~4 to 2.5 hours. We established that protein synthesis is required for posttranscriptional regulation, suggesting the involvement of an RNase and/or key mRNA stabilization factor(s) controlling the DNMT3B mRNA stability. Therefore, TSA may not only modify histone acetylation, but also potentially alter DNA methylation. Since the HDAC inhibitors are frequently used in epigenetic studies and are considered to be promising anticancer drugs, these new findings will have implications in both laboratory and clinical settings.

Key Words: DNMT3B • HDAC inhibitor • DNA methylation • epigenetics




This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
Q. Li, D. L. Bartlett, M. C. Gorry, M. E. O'Malley, and Z. S. Guo
Three Epigenetic Drugs Up-Regulate Homeobox Gene Rhox5 in Cancer Cells through Overlapping and Distinct Molecular Mechanisms
Mol. Pharmacol., November 1, 2009; 76(5): 1072 - 1081.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. S. Schrump
Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
Clin. Cancer Res., June 15, 2009; 15(12): 3947 - 3957.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
I. Lopez de Silanes, M. Gorospe, H. Taniguchi, K. Abdelmohsen, S. Srikantan, M. Alaminos, M. Berdasco, R. G. Urdinguio, M. F. Fraga, F. V. Jacinto, et al.
The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA
Nucleic Acids Res., May 1, 2009; 37(8): 2658 - 2671.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Kundakovic, Y. Chen, A. Guidotti, and D. R. Grayson
The Reelin and GAD67 Promoters Are Activated by Epigenetic Drugs That Facilitate the Disruption of Local Repressor Complexes
Mol. Pharmacol., February 1, 2009; 75(2): 342 - 354.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
D F Peng, M Razvi, H Chen, K Washington, A Roessner, R Schneider-Stock, and W El-Rifai
DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma
Gut, January 1, 2009; 58(1): 5 - 15.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L.-P. Wu, X. Wang, L. Li, Y. Zhao, S. Lu, Y. Yu, W. Zhou, X. Liu, J. Yang, Z. Zheng, et al.
Histone Deacetylase Inhibitor Depsipeptide Activates Silenced Genes through Decreasing both CpG and H3K9 Methylation on the Promoter
Mol. Cell. Biol., May 15, 2008; 28(10): 3219 - 3235.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Paradisi, N. Pasquariello, D. Barcaroli, and M. Maccarrone
Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner
J. Biol. Chem., March 7, 2008; 283(10): 6005 - 6012.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Heller, W. M. Schmidt, B. Ziegler, S. Holzer, L. Mullauer, M. Bilban, C. C. Zielinski, J. Drach, and S. Zochbauer-Muller
Genome-Wide Transcriptional Response to 5-Aza-2'-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells
Cancer Res., January 1, 2008; 68(1): 44 - 54.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C. A. Krusche, A. J. Vloet, I. Classen-Linke, U. von Rango, H. M. Beier, and J. Alfer
Class I histone deacetylase expression in the human cyclic endometrium and endometrial adenocarcinomas
Hum. Reprod., November 1, 2007; 22(11): 2956 - 2966.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Fathallah, R. S. Weinberg, Y. Galperin, M. Sutton, and G. F. Atweh
Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin
Blood, November 1, 2007; 110(9): 3391 - 3397.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
W.-Y. Chen, J.-H. Weng, C.-C. Huang, and B.-c. Chung
Histone Deacetylase Inhibitors Reduce Steroidogenesis through SCF-Mediated Ubiquitination and Degradation of Steroidogenic Factor 1 (NR5A1)
Mol. Cell. Biol., October 15, 2007; 27(20): 7284 - 7290.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. C. Dowdy, S. Jiang, X. C. Zhou, X. Hou, F. Jin, K. C. Podratz, and S.-W. Jiang
Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells.
Mol. Cancer Ther., November 1, 2006; 5(11): 2767 - 2776.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. Tzao, G.-H. Sun, H.-J. Tung, H.-S. Hsu, W.-H. Hsu, Y.-C. Wang, Y.-L. Cheng, and S.-C. Lee
Reduced Acetylated Histone H4 is Associated With Promoter Methylation of the Fragile Histidine Triad Gene in Resected Esophageal Squamous Cell Carcinoma
Ann. Thorac. Surg., August 1, 2006; 82(2): 396 - 401.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.